[Federal Register Volume 87, Number 99 (Monday, May 23, 2022)]
[Notices]
[Pages 31245-31246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10990]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held for the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The 
meeting will be open to the public; a pre-registered public comment 
session will be held during the meeting. Pre-registration is required 
for members of the public who wish to attend the meeting and who wish 
to participate in the public comment session. Individuals who wish to 
attend the meeting and/or send in their public comment via email should 
send an email to <a href="/cdn-cgi/l/email-protection#94d7d5c6d6d4fcfce7baf3fbe2"><span class="__cf_email__" data-cfemail="eaa9abb8a8aa828299c48d859c">[email protected]</span></a>. Registration information is available on 
the website http://www.hhs.gov/paccarb and must be completed by 
September 5, 2022; all in-person attendees must pre-register by this 
date and will be given priority over unregistered attendees. Additional 
information about any updates to COVID-19 safety precautions or 
requirements, including how to register for the meeting and provide 
public comment, can be obtained at http://www.hhs.gov/paccarb on the 
Meetings page. Please visit the page for frequent updates.

DATES: The meeting is tentatively scheduled to be held on September 12, 
from 9:00 a.m. to 5:00 p.m., and September 13, 2022, from 9:00 a.m. to 
5:00 p.m. ET (all times are subject to change). The confirmed times and 
agenda items for the meeting will be posted on the website for the 
PACCARB at http://www.hhs.gov/paccarb when this information becomes 
available. Pre-registration for attending the meeting in person is 
required to be completed no later than September 5, 2022; public 
attendance at the meeting is limited to the available space.

ADDRESSES: Tysons Corner Marriott, 8028 Leesburg Pike, Tysons Corner, 
Virginia 22182. The meeting can also be accessed through a live webcast 
and via teleconference on the day of the meeting. For more information, 
visit http://www.hhs.gov/paccarb.

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Room L616, Switzer Building, 
330 C St. SW, Washington, DC 20201. Email: <a href="/cdn-cgi/l/email-protection#783b392a3a3810100b561f170e"><span class="__cf_email__" data-cfemail="3d7e7c6f7f7d55554e135a524b">[email protected]</span></a>. Telephone: 
(202) 746-1512.

SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria (PACCARB), established by 
Executive Order 13676, is continued by Section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation 
Act of 2019 (PAHPAIA). Activities and duties of the Advisory Council 
are governed by the provisions of the Federal Advisory Committee Act 
(FACA), Public Law 92-463, as amended (5 U.S.C. App.), which sets forth 
standards for the formation and use of federal advisory committees.
    The PACCARB shall advise and provide information and 
recommendations to the Secretary regarding programs and policies 
intended to reduce or combat antibiotic-resistant bacteria that may 
present a public health threat and improve capabilities to prevent, 
diagnose, mitigate, or treat such resistance. The PACCARB shall 
function solely for advisory purposes.
    Such advice, information, and recommendations may be related to 
improving: The effectiveness of antibiotics; research and advanced 
research on, and the development of, improved and innovative methods 
for combating or reducing antibiotic resistance, including new 
treatments, rapid point-of-care diagnostics, alternatives to 
antibiotics, including alternatives to animal antibiotics, and 
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health 
care providers and the public with respect to up-to-date information on 
antibiotic resistance and ways to reduce or combat such resistance to 
antibiotics related to humans and animals; methods to prevent or reduce 
the transmission of antibiotic-resistant bacterial infections; 
including stewardship programs; and coordination with respect to 
international efforts in order to inform and advance the United States 
capabilities to combat antibiotic resistance.
    The September 12-13, 2022 public meeting will be dedicated to a One 
Health AMR and Pandemic Preparedness Policy Workshop with the goal of 
identifying key issues and critical policy gaps through a series of 
facilitated discussions examining a hypothetical large-scale disease 
outbreak scenario based on historic examples and estimates of future 
AMR

[[Page 31246]]

outbreaks. The meeting agenda will be posted on the PACCARB website at 
http://www.hhs.gov/paccarb when it has been finalized. All agenda items 
are tentative and subject to change.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the PACCARB by emailing <a href="/cdn-cgi/l/email-protection#2d6e6c7f6f6d45455e034a425b"><span class="__cf_email__" data-cfemail="eaa9abb8a8aa828299c48d859c">[email protected]</span></a> at least one week prior to 
the meeting. For those unable to attend in person, a live webcast will 
be available. More information on registration and accessing the 
webcast can be found at http://www.hhs.gov/paccarb.
    Members of the public will have the opportunity to provide comments 
during and prior to the PACCARB meeting by indicating their preference 
in their registration available on the PACCARB website at http://www.hhs.gov/paccarb and/or by emailing <a href="/cdn-cgi/l/email-protection#a1e2e0f3e3e1c9c9d28fc6ced7"><span class="__cf_email__" data-cfemail="1350524151537b7b603d747c65">[email protected]</span></a>. Public comments 
can also be sent in by mail, and if so, correspondence should be sent 
in by midnight September 5, 2022, and should be limited to no more than 
one page. All public comments received prior to September 5, 2022, will 
be provided to PACCARB members. Additionally, companies and/or 
organizations involved in combating antibiotic resistance have an 
opportunity to present their work to members of the PACCARB during an 
Innovation Spotlight. Pre-registration is required for participation, 
with limited spots available. All information regarding this session 
can also be found online at http://www.hhs.gov/paccarb.

    Dated: May 13, 2022.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for 
Health.
[FR Doc. 2022-10990 Filed 5-20-22; 8:45 am]
BILLING CODE 4150-44-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>